MUC1 and pancreatic neoplasm: Anurathapan et al. demonstrated that decitabine could increase the expression level of mucin 1 (MUC1) by demethylating DNA in downregulated MUC1-antigen expression and resistant CAPAN1 pancreatic tumor cells.